Sumoylation of PPARγ Contributes to Vascular Endothelium Insulin Resistance Through Stabilizing the PPARγ–NcoR Complex

Dongyi Lan,Xiaodan Shen,Wanwan Yuan,Yumeng Zhou,Qiren Huang
DOI: https://doi.org/10.1002/jcp.28567
2019-01-01
Journal of Cellular Physiology
Abstract:Sumoylation of peroxisome proliferator-activated receptor gamma (PPAR gamma) affects its stabilization, sublocalization, and transcriptional activity. However, it remains largely unknown whether PPAR gamma sumoylation inhibits the transactivation effect, leading to endothelium insulin resistance (IR). To test this possibility, human umbilical vascular endothelial cells (HUVECs) with a 90% confluence were randomly allocated to two batches. One batch was first pretreated with or without vitamin E for 24hr and the other infected with adenoviruses containing either PIAS1-shRNA (protein inhibitor of activated STAT1-short hairpin RNA) or scramble shRNA. Cells were suffered from high glucose and palmitic acid (PA) exposure for further 48hr. The levels of PPAR gamma, p-IKK, IKK, and NcoR (nuclear corepressors) were measured by western blot analysis. The interaction of IKK and PIAS1, as well as the PPAR gamma sumoylation, were examined by coimmunoprecipitation. The results showed that the exposure of high glucose and PAinduced reactive oxygen species (ROS) production and IKK activation in HUVECs, promoting the interaction of IKK and PIAS1 and the sumoylation of PPAR gamma. However, vitamin E and PIAS1-shRNA partially decreased ROS production and IKK activation induced by high glucose and PA exposure. These data indicate that ROS-IKK-PIAS1 pathway mediates PPAR gamma sumoylation, leading to endothelium IR via stabilizing PPAR gamma-NcoR complex. These findings benefit understanding of regulatory networks of insulin signaling, which might provide a potential target to prevent and cure IR-related diseases.
What problem does this paper attempt to address?